Showing results (401-410 of 435) with videos related to

Sort By:
Pageof 44
Proceedings of the National Academy of Sciences of the United States of America|December 3, 2008
HDAC2 blockade by nitric oxide and histone deacetylase inhibitors reveals a common target in Duchenne muscular dystrophy treatmentClaudia Colussi, Chiara Mozzetta, Aymone Gurtner, et al.
ACS Medicinal Chemistry Letters|September 19, 2019
Correction to "Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's Disease"Angela De Simone, Valeria La Pietra, Nibal Betari, et al.
ACS Pharmacology & Translational Science|February 20, 2025
Spirotetrahydroisoquinoline-Based Histone Deacetylase Inhibitors as New Antifibrotic Agents: Biological Evaluation in Human Fibroblasts from Bronchoalveolar Lavages of Idiopathic Pulmonary Fibrosis PatientsAnna Fontana, Laura Bergantini, Gabriele Carullo, et al.
Cancers|January 1, 2020
Inhibition of Histone Demethylases LSD1 and UTX Regulates ERα Signaling in Breast CancerRosaria Benedetti, Carmela Dell'Aversana, Tommaso De Marchi, et al.
ACS Medicinal Chemistry Letters|April 19, 2019
Discovery of the First-in-Class GSK-3β/HDAC Dual Inhibitor as Disease-Modifying Agent To Combat Alzheimer's DiseaseAngela De Simone, Valeria La Pietra, Nibal Betari, et al.
Aging Cell|November 18, 2025
Electron Microscopy and Multi-Omics Reveal Mitochondrial Dysfunction and Structural Remodeling in the Hearts of Elderly MiceManuela Giovanna Basilicata, Marco Malavolta, Serena Marcozzi, et al.
Cell Reports|November 17, 2016
Distinct Trends of DNA Methylation Patterning in the Innate and Adaptive Immune SystemsRonald P Schuyler, Angelika Merkel, Emanuele Raineri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 15, 2018
RIP1-HAT1-SIRT Complex Identification and Targeting in Treatment and Prevention of CancerVincenzo Carafa, Angela Nebbioso, Francesca Cuomo, et al.
ACS Pharmacology & Translational Science|July 18, 2024
Development of Epigenetic Modifiers with Therapeutic Potential in FMS-Related Tyrosine Kinase 3/Internal Tandem Duplication (FLT3/ITD) Acute Myeloid Leukemia and Other Blood MalignanciesGabriele Carullo, Sara Rossi, Valentina Giudice, et al.
European Journal of Medicinal Chemistry|July 25, 2024
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sitesAnna Maria Trotta, Stefano Tomassi, Gaetana Di Maiolo, et al.
Pageof 44